Consistent with these in vitro findings, flow cytometric analysis of PBMCs from SSc patients after MSC therapy showed a significant decrease in the frequencies of both CD3+PD-1+ and CD4+PD-1+ T cells (figure 5D,E). Here, CD4 is linked to systemic sclerosis.